CollPlant to Present at the International Conference on Biofabrication 2022 in Tuscany, Italy

Rhea-AI Summary

CollPlant (NASDAQ: CLGN) announced its participation at the International Conference on Biofabrication in Tuscany, Italy, from September 25 to 28, 2022. The company will present on "Recombinant Human Collagen-based Bioinks for Biofabrication and Modeling Applications" on September 28 during the symposium from 9:00 AM to 10:30 AM CET. CollPlant focuses on innovative solutions in tissue regeneration and organ manufacturing using its proprietary rhCollagen technology, and will feature an exhibition booth at the conference.

REHOVOT, Israel, Sept. 19, 2022 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative human collagen-based technologies and products for tissue regeneration and organ manufacturing, today announced the Company will make a presentation on "Recombinant Human Collagen-based Bioinks for Biofabrication and Modeling Applications" at the International Conference on Biofabrication on September 28^th. CollPlant will also have an exhibition booth at the Conference from Sept 25^th-28^th.   

• Exhibition booth #6
• Presentation title: "Recombinant Human Collagen-based Bioinks for Biofabrication and Modeling Applications"
• Session name: Commercial applications & Technology Transfer
• Date: Wednesday, September 28, 2022
• Symposia time: 9:00 AM - 10:30 AM CET

About CollPlant

CollPlant is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs, and medical aesthetics. The Company's products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing, and are ushering in a new era in regenerative and aesthetic medicine.

At the beginning of 2021, CollPlant entered into a development and global commercialization agreement for dermal and soft tissue fillers with Allergan, an AbbVie company, the global leader in the dermal filler market. Later in 2021, CollPlant entered a strategic co-development agreement with 3D Systems for a 3D bioprinted regenerative soft tissue matrix for use in breast reconstruction procedures in combination with an implant.

For more information about CollPlant, visit http://www.collplant.com

Contact at CollPlant:
Eran Rotem
Deputy CEO & CFO
Tel: + 972-73-2325600
Email: Eran@CollPlant.com

Photo - https://mma.prnewswire.com/media/1901297/CollPlant_at_ISBF.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/collplant-to-present-at-the-international-conference-on-biofabrication-2022-in-tuscany-italy-301627000.html

SOURCE CollPlant

FAQ

When will CollPlant present at the International Conference on Biofabrication 2022?

CollPlant will present on September 28, 2022.

What is the title of CollPlant's presentation at the conference?

The presentation is titled 'Recombinant Human Collagen-based Bioinks for Biofabrication and Modeling Applications.'

Where will the International Conference on Biofabrication 2022 take place?

The conference will be held in Tuscany, Italy.

What are the dates for the International Conference on Biofabrication?

The conference will occur from September 25 to September 28, 2022.

What is CollPlant's focus regarding tissue regeneration?

CollPlant specializes in developing human collagen-based technologies for tissue regeneration and organ manufacturing.

Where can I find more information about CollPlant?

More information can be found on CollPlant's website at www.collplant.com.